يحاول ذهب - حر
Ireland Provides an Easy Market Into Europe
December 2016
|Bio Spectrum
Sahajanand Medical Technologies (SMt) is developer and manufacturer of minimal-ly invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. the company has received numerous awards for its breakthrough innovations and quality, that have led to thinner and more flexible DES (drug-eluting stents) with good long term clinical results.
SMT is establishing its European headquarters, including Research, Development and Innovation centre in Ireland. We chat with SMt’s Western European Head, Gaurav Goel, to know more about it.
Gaurav Goel
Western European Head, Sahajanand Medical Technologies (SMT)
Q: What is the rationale behind setting up an office in Ireland?
A: Ireland is well known as the medical device hub of the world. 15 of the top 20 global medtech companies operate in Ireland. Ireland provides a complete eco-system in terms of infrastructure, highly skilled manpower, raw material and capital goods suppliers at close proximity. When SMT wanted to expand into the European market, it scouted various countries in Europe. The major thrust was to find out a suitable country where we could address our multiple requirements and Ireland was our answer. Ireland fits perfectly into our short term and long term goals. We look forward to bringing together our Indian talent along with the high skilled manpower available in Ireland to become a major global medical device player.
Q: Could you please throw some light on SMt’s product portfolio? What are your areas of focus as far as product services are concerned?
هذه القصة من طبعة December 2016 من Bio Spectrum.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Bio Spectrum
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

